NCT03951883

Brief Summary

Quality nutrient intake is essential for proper development and well-being of children in all aspects of health, including cognitive development. Eggs are of particular interest based on potential cognitive and neurological benefits due in part to significant concentrations of choline and lutein. While overall, choline and lutein have received considerable attention in the literature in relation to cognition and brain function, most studies involving intake in young adults have had short intervention periods ranging from 90 minutes to 3 days. Food insecurity has been associated with decreased academic performance. Given that populations with food insecurity have limited resources to direct towards nutrition, identifying how a widely available, highly versatile and largely affordable source of nutrients (i.e. eggs) may have favorable impacts on cognitive function and brain function will be valuable in informing public health recommendations in this at-risk population. As such the investigators will examine whether an increased egg consumption dietary prescription can have positive effects on functional activity (i.e. fMRI) during an Eriksen-Flanker task, anatomical changes in the brain (i.e. DTI, MRI), and cognitive abilities as measured by the Stop Signal Reaction Time task, Operation Span task, Raven's Progressive Matrices and the Boston Naming Task.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2019

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2019

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

May 10, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 16, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

November 11, 2021

Status Verified

November 1, 2021

Enrollment Period

1.8 years

First QC Date

May 10, 2019

Last Update Submit

November 9, 2021

Conditions

Outcome Measures

Primary Outcomes (8)

  • Comparison of functional activity during Eriksen-Flanker Task

    Changes in regional brain activation during an fMRI scan.

    Baseline (pre-intervention) and 12 weeks (post-intervention)

  • Comparison of grey matter anatomical change

    Grey density as measured by MRI

    Baseline (pre-intervention) and 12 weeks (post-intervention)

  • Comparison of white matter connectivity change

    White matter connectivity as measured by diffusion tensor imaging

    Baseline (pre-intervention) and 12 weeks (post-intervention)

  • Comparison of cognitive battery performance change

    Cognitive performance as measured by stop signal reaction time task

    Baseline (pre-intervention) and 12 weeks (post-intervention)

  • Comparison of cognitive battery performance change

    Cognitive performance as measured by operation span task

    Baseline (pre-intervention) and 12 weeks (post-intervention)

  • Comparison of cognitive battery performance change

    Cognitive performance as measured by Raven's Progressive Matrices

    Baseline (pre-intervention) and 12 weeks (post-intervention)

  • Comparison of cognitive battery performance change

    Cognitive performance as measured by Boston Naming Task

    Baseline (pre-intervention) and 12 weeks (post-intervention)

  • Comparison of Eriksen-Flanker Task performance change

    Eriksen-Flanker task performance compared using the drift diffusion model

    Baseline (pre-intervention) and 12 weeks (post-intervention)

Study Arms (2)

Typical Diet (TD)

ACTIVE COMPARATOR

Participants will be instructed to continue habitual dietary intake.

Other: Typical diet

Increased Egg Consumption (IE)

EXPERIMENTAL

Participants will be prescribed an additional 2 eggs per day to their diet.

Other: Increased Egg Consumption

Interventions

Subjects will be instructed to use a weekly food purchase supplement for inclusion of 2 additional eggs per day to be added to subject's typical daily diet.

Increased Egg Consumption (IE)

Subjects will be instructed to maintain their current dietary patterns.

Typical Diet (TD)

Eligibility Criteria

Age13 Years - 19 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age: 13-19 years.
  • Household has food security status of low or very low as designated by scoring 2-6 raw score using the U.S. Household Food Security Survey Module: Six-Item Short Form.

You may not qualify if:

  • Participants unable or unwilling to provide informed consent.
  • Participants with motor, visual or hearing impairment.
  • Participants with current severe psychiatric illnesses (e.g. psychosis, schizophrenia, bipolar disorders, depression)
  • Participants with history of psychiatric hospitalization.
  • Participants with habitual egg consumption (past 3 months) of 4 eggs per week or more
  • Unable or unwilling to consume required study meals for any reason (e.g. dietary restrictions, allergies, or aversions to any of the food items used in the study).
  • History of liver or kidney disease, cardiovascular disease, hematologic disease, metabolic disease, Epilepsy (or other seizure disorder) or malignant tumor
  • Currently taking (or have taken in the past 4 weeks) any anti-anxiolytic, anti-epileptic, or anti-depression medications
  • Currently taking (or have taken in the past 4 weeks) any proton pump inhibitor medications
  • History of any cognitive disorder, medical and/or psychological conditions and/or medications affecting cognition
  • Participants with contraindications for MRI scanning.
  • aneurism clips
  • any implanted medical devices (pacemaker, neurostimulator)
  • known pregnancy
  • shrapnel in body or any injury to eye involving metal
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Texas Tech Neuroimaging Institute

Lubbock, Texas, 79409, United States

Location

Nutrition & Metabolic Health Initiative

Lubbock, Texas, 79410, United States

Location

Study Officials

  • Martin Binks, PhD

    Texas Tech University- Department of Nutritional Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 10, 2019

First Posted

May 16, 2019

Study Start

May 1, 2019

Primary Completion

March 1, 2021

Study Completion

March 1, 2021

Last Updated

November 11, 2021

Record last verified: 2021-11

Locations